An 11-Year Review of Lactobacillus Bacteremia at a Pediatric Tertiary Care Center

Yosefa Hefter1, Lauren Powell1, Christine E Tabulov2

  • 1Divisions of Infectious Diseases.

Hospital Pediatrics
|May 19, 2023
PubMed

Insights

Lactobacillus bacteremia is rare in pediatric inpatients, with only 8 cases over 11 years. Probiotic use did not correlate with increased bacteremia, but certain patient factors indicate higher risk.

Area of Science:

  • Microbiology
  • Pediatric Infectious Diseases
  • Clinical Pharmacy

Background:

  • Probiotics are widely used in pediatric care.
  • The risk of Lactobacillus bacteremia in hospitalized children is not well-defined.
  • Informing clinical decisions requires understanding bacteremia incidence and risk factors.

Purpose of the Study:

  • To determine the incidence of Lactobacillus bacteremia in pediatric inpatients.
  • To identify patient characteristics and risk factors associated with Lactobacillus bacteremia.
  • To assess the correlation between probiotic administration and bacteremia rates.

Main Methods:

  • Retrospective review of 8 cases of Lactobacillus bacteremia over 11 years in a tertiary-care pediatric hospital.
  • Analysis of patient charts for symptoms, risk factors (probiotic use, central venous catheter, immunocompromise, intestinal dysfunction, age <3 months).
  • Assessment of concurrent inpatient probiotic administration data.

Main Results:

  • Eight cases of Lactobacillus bacteremia identified among 127,845 admissions.
  • All cases presented with systemic signs of infection.
  • Frequent risk factors included impaired intestinal function and central venous catheters; 3 cases had prior probiotic use.
  • Bacteremia incidence did not correlate with peak probiotic administration periods.

Conclusions:

  • Lactobacillus bacteremia is uncommon in pediatric inpatients and not directly correlated with hospital probiotic administration volumes.
  • Certain patient populations, particularly those with impaired intestinal function or central venous catheters, may be at increased risk.
  • Clinical decisions regarding probiotic use in vulnerable pediatric populations require careful consideration of individual risk factors.
Abstract